These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2718200)

  • 21. Dipyridamole plus aspirin in cerebrovascular disease.
    Wilterdink JL; Easton JD
    Arch Neurol; 1999 Sep; 56(9):1087-92. PubMed ID: 10488809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet activation in acute cerebral ischaemia. Serial measurements of platelet function in cerebrovascular disease.
    Dougherty JH; Levy DE; Weksler BB
    Lancet; 1977 Apr; 1(8016):821-4. PubMed ID: 67334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on clinical trials of antiplatelet therapy for cerebrovascular diseases.
    Bhatt DL; Kapadia SR; Yadav JS; Topol EJ
    Cerebrovasc Dis; 2000; 10 Suppl 5():34-40. PubMed ID: 11096181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharma-clinics. The drug of the month. Dipyridamole-acetylsalicylic acid combination (Aggrenox)].
    Scheen AJ
    Rev Med Liege; 2000 Oct; 55(10):957-9. PubMed ID: 11244807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of dipyridamole and aspirin on shear-induced platelet aggregation in whole blood and platelet-rich plasma.
    Nakamura T; Uchiyama S; Yamazaki M; Iwata M
    Cerebrovasc Dis; 2002; 14(3-4):234-8. PubMed ID: 12403957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiplatelet therapy in cerebrovascular disorders.
    Weber R; Brenck J; Diener HC
    Handb Exp Pharmacol; 2012; (210):519-46. PubMed ID: 22918745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual Therapy with Aspirin and Cilostazol May Improve Platelet Aggregation in Noncardioembolic Stroke Patients: A Pilot Study.
    Ohnuki Y; Ohnuki Y; Kohara S; Shimizu M; Takizawa S
    Intern Med; 2017; 56(11):1307-1313. PubMed ID: 28566591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is treatment with aspirin combined with dipyridamole really more cost-effective than aspirin alone?
    Heidebrink JL
    Arch Intern Med; 2001 May; 161(9):1236. PubMed ID: 11343453
    [No Abstract]   [Full Text] [Related]  

  • 31. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
    Serebruany VL; Malinin AI; Sane DC
    Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does the association dipyridamole-aspirin only act by a functional synergism?
    De la Cruz JP; Sanchez de la Cuesta F
    Gen Pharmacol; 1991; 22(2):271-4. PubMed ID: 2055420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of low dose aspirin on platelet function in patients with recent cerebral ischemia.
    Weksler BB; Kent JL; Rudolph D; Scherer PB; Levy DE
    Stroke; 1985; 16(1):5-9. PubMed ID: 3966266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of treatment with aspirin or aspirin/dipyridamole combination in heartworm-negative, heartworm-infected, and embolized heartworm-infected dogs.
    Boudreaux MK; Dillon AR; Ravis WR; Sartin EA; Spano JS
    Am J Vet Res; 1991 Dec; 52(12):1992-9. PubMed ID: 1789513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADP-induced platelet aggregation in acute ischemic stroke patients on aspirin therapy.
    Cha JK; Jeon HW; Kang MJ
    Eur J Neurol; 2008 Dec; 15(12):1304-8. PubMed ID: 19049546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors and antiplatelet therapy in TIA and stroke patients.
    Puranen J; Laakso M; Riekkinen P; Sivenius J
    J Neurol Sci; 1998 Feb; 154(2):200-4. PubMed ID: 9562311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antithrombotic treatment as primary and secondary prevention of stroke].
    Chukanova EI; Chukanova AS; Nadareyshvili GG; Gulieva MS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):85-88. PubMed ID: 28635860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dipyridamole decreases protease-activated receptor and annexin-v binding on platelets of post stroke patients with aspirin nonresponsiveness.
    Serebruany V; Malinin A; Ziai W; Atar D; Pokov A; Jilma B; Hanley D
    Cerebrovasc Dis; 2006; 21(1-2):98-105. PubMed ID: 16340184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effects of ligustrazine, aspirin and beta-histine on platelet aggregation in patients with acute ischemic stroke].
    Gao BT
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Jun; 22(3):148-51, 191. PubMed ID: 2591268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.